|
Jul 2
|
Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna.
|
|
Jul 2
|
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
|
|
Jul 2
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
|
Jul 1
|
Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?
|
|
Jul 1
|
Moderna Stock Gains on Encouraging Flu Vaccine Data
|
|
Jul 1
|
GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
|
|
Jun 30
|
Gilead extends gains after Supreme Court upheld an Obamacare provision
|
|
Jun 28
|
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 27
|
Sector Update: Health Care Stocks Retreat Late Afternoon
|
|
Jun 27
|
Sector Update: Health Care Stocks Mixed Friday Afternoon
|
|
Jun 27
|
Top Midday Stories: S&P 500, Nasdaq Hit Record Highs; Fed's Preferred Inflation Gauge Rises Above Expectations
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 25
|
Sector Update: Health Care Stocks Advance Late Afternoon
|
|
Jun 25
|
Sector Update: Health Care Stocks Softer Wednesday Afternoon
|
|
Jun 25
|
Bharat, GSK to halve price of malaria vaccine by 2028
|
|
Jun 24
|
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
|
|
Jun 24
|
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
|
|
Jun 23
|
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
|
|
Jun 19
|
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
|